The Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease (GBD) study is the largest and most comprehensive effort to quantify health loss across places and over time, so health systems can be improved and disparities eliminated.
An independent population health research organization based at the University of Washington School of Medicine, the Institute for Health Metrics and Evaluation (IHME) works with collaborators around the world to develop timely, relevant, and scientifically valid evidence that illuminates the state of health everywhere. In making our research available and approachable, we aim to inform health policy and practice in pursuit of our vision: all people living long lives in full health.
In relation to asbestos exposure and the disease burden, the 2023 GBD study global estimates for deaths and disability adjusted life years (DALYs) per year are as follows:
| Disease | Deaths | DALYs |
| Tracheal, Bronchus & lung cancer | 195,542 | 3,430,039 |
| Mesothelioma | 25,664 | 530,723 |
| Ovarian Cancer | 5,837 | 102,577 |
| Larynx Cancer | 3,657 | 72,523 |
| Asbestosis | 3,012 | 57,923 |